Purdue Pharma reaches settlement with feds: Baton Rouge case still in the works

    Purdue Pharma, the maker of OxyContin, has reached a $8.34 billion settlement with the U.S. Justice Department and agreed to plead guilty to three felonies over its role in the nation’s opioid crisi…

    Already a subscriber? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.